SCHEMBL22856426

SCHEMBL22856426

CCCCOC1CCN(C(C)=O)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.46
KDM4E B2RXH2 1/20 0.46
USP2 O75604 1/20 0.46
ALOX15 P16050 1/20 0.46
LIPC P11150 1/20 0.42
LIPG Q9Y5X9 1/20 0.42
HPGD P15428 1/20 0.41
MAPT P10636 2/20 0.40
LSS P48449 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
LMNA P02545 2/20 0.38
POLB P06746 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
EPHX2 P34913 3/20 0.37
GNAI3 P08754 1/20 0.37
GNAO1 P09471 1/20 0.37
GNAI1 P63096 1/20 0.37
PTBP1 P26599 1/20 0.37
HIF1A Q16665 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22526238 0.92 ALDH1A1 (0.46) ALDH1A1KDM4EUSP2ALOX15LIPC
SCHEMBL13892243 0.89 KDM4E (0.41) ALDH1A1KDM4EUSP2ALOX15MAPT
SCHEMBL22861849 0.87 KDM4E (0.42) ALDH1A1KDM4EUSP2ALOX15HPGD
SCHEMBL5270128 0.86 LIPC (0.42) ALDH1A1KDM4EUSP2ALOX15LIPC
SCHEMBL9030287 0.85 KMT2A (0.39) LSSRAB9AEPHX2EPHX1
SCHEMBL11472234 0.82 EPHX2 (0.39) KDM4ELIPGMAPTSMN1; SMN2EPHX2
SCHEMBL24672696 0.82 PIK3CD (0.41) ALDH1A1KDM4EUSP2ALOX15LSS
SCHEMBL22526538 0.82 HRH2 (0.42) ALDH1A1KDM4ELIPCLIPGHPGD
SCHEMBL26404242 0.82 LSS (0.36) ALDH1A1KDM4EUSP2ALOX15MAPT
SCHEMBL13349907 0.82 LIPC (0.40) ALDH1A1KDM4EUSP2ALOX15LIPC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023192586-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-10-05 WO disclosed
WO-2022266206-A1 KRAS INHIBITOR CONJUGATES ERASCA, INC. (US) 2022-12-22 WO disclosed
WO-2022125800-A1 SMARCA DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2022-06-16 WO disclosed
WO-2021127190-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2021-06-24 WO disclosed
WO-2021011868-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2021-01-21 WO disclosed
WO-2021011634-A1 PROTEIN DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2021-01-21 WO disclosed
WO-2020264490-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2020-12-30 WO disclosed